- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.07. | UPEXI, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 09.07. | Upexi Inc reports results for the quarter ended in March - Earnings Summary | 1 | Reuters | ||
| 09.07. | UPEXI, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 05.07. | Upexi Inc expected to post a loss of 10 cents a share - Earnings Preview | 1 | Reuters | ||
| 02.07. | UPEXI, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.06. | Upexi Inc expected to post a loss of 10 cents a share - Earnings Preview | 1 | Reuters | ||
| 21.06. | Upexi, Inc.: Upexi Provides Update on Filing Form 10Q for March 31, 2024 | 303 | ACCESSWIRE | TAMPA, FL / ACCESSWIRE / June 21, 2024 / Upexi, Inc. (NASDAQ:UPXI) (the "Company" or "Upexi"), a multi-faceted Amazon and Direct-to-Consumer ("DTC") brand owner and innovator in aggregation, today is... ► Artikel lesen | |
| 21.06. | UPEXI, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 20.06. | Upexi updates on restructuring aimed at reducing debt and increasing working capital | 1 | Seeking Alpha | ||
| 20.06. | Upexi, Inc.: Upexi Provides Shareholders with Update on Restructuring to Reduce Debt and Increase Working Capital through Sale of Assets | 241 | ACCESSWIRE | TAMPA, FL / ACCESSWIRE / June 20, 2024 / Upexi, Inc. (NASDAQ:UPXI) (the "Company" or "Upexi"), a multi-faceted Amazon and Direct-to-Consumer ("DTC") brand owner and innovator in aggregation, today is... ► Artikel lesen | |
| 07.06. | Upexi Inc expected to post a loss of 10 cents a share - Earnings Preview | 2 | Reuters | ||
| 07.06. | UPEXI, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.06. | Upexi, Inc.: Upexi Completes Consolidation of Operations and Announces Initiating Process to Explore Strategic Alternatives to Enhance Shareholder Value | 120 | ACCESSWIRE | Consolidation of operations will reduce operating expenses by $2-$3 million annuallyIn process to engage investment bank for strategic alternatives TAMPA, FL / ACCESSWIRE / June 6, 2024 / Upexi, Inc.... ► Artikel lesen | |
| 28.05. | UPEXI, INC. - 8-K, Current Report | - | SEC Filings | ||
| 15.05. | UPEXI, INC. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 2 | SEC Filings | ||
| 13.05. | Upexi Inc expected to post a loss of 10 cents a share - Earnings Preview | 1 | Reuters | ||
| 07.05. | UPEXI, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.04. | UPEXI, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.03. | UPEXI, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.03. | Upexi, Inc.: Upexi's Tytan Tile Kits, Disney Frozen and New Disney JR Mikey Mouse Set, will Soon be Available in BJ's Wholesale Club | 375 | ACCESSWIRE | BJ's is Tytan's second leading retailer to add Disney Frozen and the first with Disney JR Mickey Mouse tile kitUpexi launches second Disney character product line with new Mikey Mouse tile kitTAMPA... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
49 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 5,410 | -0,55 % | Vor den Zahlen: Bahnt sich bei Canopy Growth, Aurora Cannabis & Co. die Trendwende an? | © Foto: adobe.stock.comDie US-Wahlen werfen ihre Schatten voraus. Auch im Cannabis-Sektor verfolgt man die aktuellen Entwicklungen mit Argusaugen. Zuletzt ließ eine Meldung die Kurse von Canopy Growth... ► Artikel lesen | |
| CANOPY GROWTH | 6,750 | +0,45 % | Stocks in Play: Canopy Growth Corporation | ||
| TILRAY BRANDS | 1,681 | -0,53 % | Tilray Brands, Inc.: Tilray erhält erste neue Cannabis-Anbaulizenz in Deutschland nach neuen Vorschriften | Aphria RX-Anlage von Tilray in Deutschland erhält neue Cannabis-Anbaulizenz, die eine ca. 5-fache Produktionssteigerung und neue Sorten ermöglicht, um den Zugang für Patienten im ganzen Land zu verbessern
Aphria... ► Artikel lesen | |
| TEVA | 15,750 | -0,32 % | Teva Pharmaceutical Industries Limited: Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease | Enrollment acceleration drives earlier-than-anticipated data availability for this potentially best-in-class IBD treatment
Topline results for both UC and CD now anticipated in Q4 2024... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 458,75 | +0,54 % | Is Vertex Pharmaceuticals' Monopoly in Danger? | ||
| ABBOTT LABORATORIES | 97,17 | +0,25 % | Abbott must pay $95 million in premature infant formula trial, jury finds | ||
| MPH HEALTH CARE | 23,200 | -3,33 % | Dividendenbekanntmachungen (19.07.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ATTICA HOLDINGS SA GRS144003001 - 0,07 EUR BOSTON PIZZA ROYALTIES INCOME FUND CA1010841015 0,113 CAD 0,0756 EUR COLGATE-PALMOLIVE... ► Artikel lesen | |
| CRONOS GROUP | 2,202 | -1,43 % | Cronos Group Inc: Cronos to hold Q2 results call Aug. 8 | ||
| VIATRIS | 11,150 | +0,18 % | Kursgewinne für die Viatris-Aktie (11,0505 €) | Am US-amerikanischen Aktienmarkt notiert die Aktie von Viatris derzeit ein wenig fester. Der jüngste Kurs betrug 12,00 US-Dollar. Ein Kursplus in Höhe von 24 Cent erfreut derzeit die Aktionäre von Viatris.... ► Artikel lesen | |
| BEVCANNA ENTERPRISES | 0,433 | -5,25 % | Bevcanna Enterprises Inc (3): Bevcanna to acquire Greenflame Distribution for $2.5M | ||
| EYEPOINT PHARMACEUTICALS | 8,750 | +4,42 % | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
| INCYTE | 63,54 | +0,54 % | Analyst Ratings For Incyte | ||
| BAUSCH HEALTH | 5,533 | +0,20 % | Bausch Health Companies Inc.: Bausch Health Responds to Market Rumors | LAVAL, QC / ACCESSWIRE / July 24, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") has become aware of a news article issued by Reorg® today, citing unnamed sources.The article... ► Artikel lesen | |
| XTACY THERAPEUTICS | 0,017 | 0,00 % | Xtacy Therapeutics Corp: Xtacy adjusts shares-for-debt deal to be for $179,025 | ||
| CRESCO LABS | 1,455 | -1,36 % | Cresco Labs Inc: Cresco Labs to release Q2 2024 financial results Aug. 8 |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu UPEXI INC finden Sie auf Wallstreet Online.
